CompletedPhase 3NCT00978068

HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children

Studying Malaria

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Francisco
Principal Investigator
Diane V Havlir, MD
University of California, San Francisco
Intervention
Lopinavir/Ritonavir (LPV/r)(drug)
Enrollment
176 enrolled
Eligibility
10 years · All sexes
Timeline
20092013

Study locations (1)

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00978068 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria

← Back to all trials